- BNF:
- Not listed
- Status:
- Red
- Decision Date:
- April 2023
Comments
RED:
- NICE HST23: for treating paediatric-onset hypophosphatasia (replaces HST6)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again
